Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in th ...
Phase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Phase 3 Randomized, Controlled Study of AAV5-RPGRfor the Treatment of X-linked Retinitis Pigmentosa ...
X-Linked Retinitis Pigmentosa
Biological: Genetic: AAV5-RPGR
MeiraGTx UK II Ltd
Janssen Research & Development, LLC
Recruiting
3 Years
N/A
All
96
Phase 3
United States;Denmark;France;Israel;Netherlands;Spain;Switzerland;United Kingdom
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Vari ...
Follow-up Phase 3 Randomized, Controlled Study of AAV5-RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene Follow-up Phase 3 Randomized, Controlled Study of AAV5-RPGRfor the Treatment of X-linked Retinitis P ...